Silexion Therapeutics Corp [NASDAQ: SLXN] surged by $0.1 during the normal trading session on while it closed the day at $0.33.
Silexion Therapeutics Corp stock has also gained 35.90% of its value over the past 7 days. However, SLXN stock has declined by -80.86% in the 3 months of the year. Over the past six months meanwhile, it has lost -96.93% and lost -96.93% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for SLXN stock reached $4.80 million, with 3.87 million shares outstanding and 2.18 million shares in the current float. Compared to the average trading volume of 2.74M shares, SLXN reached a trading volume of 199616636 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Silexion Therapeutics Corp [SLXN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLXN shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLXN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Silexion Therapeutics Corp is set at 0.07 The Price to Book ratio for the last quarter was 0.51, with the Price to Cash per share for the same quarter was set at 0.41.
SLXN stock trade performance evaluation
Silexion Therapeutics Corp [SLXN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.90. With this latest performance, SLXN shares dropped by -25.96% in over the last four-week period, additionally sinking by -96.93% over the last 6 months – not to mention a drop of -96.65% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLXN stock in for the last two-week period is set at 44.05, with the RSI for the last a single of trading hit 63.42, and the three-weeks RSI is set at 41.94 for Silexion Therapeutics Corp [SLXN]. The present Moving Average for the last 50 days of trading for this stock 0.4442, while it was recorded at 0.2438 for the last single week of trading.
Silexion Therapeutics Corp [SLXN]: An insightful look at the core fundamentals
Silexion Therapeutics Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.75 and a Current Ratio set at 1.75.
